Philips launches EXIT-CVD studies; stock last at USD 25.49 on October 15, 2026
Published on 10/16/2026 at 07:39 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSStudies and reporting date ahead
- Philips listed the EXIT-CVD clinical-studies launch on October 15, 2026.
- Philips stock was last quoted at USD 25.49 on October 15, 2026.
- Philips will publish third-quarter 2026 results on November 3, 2026, at 7:00 a.m. CET.
Philips announced the launch of the EXIT-CVD cardiovascular research project on October 15, 2026, according to the company’s investor-relations page. The page lists the project under Philips’ press releases as “EXIT-CVD research consortium launches clinical studies to transform cardiovascular care across Europe.”
Last quoted price
Philips stock was last quoted at USD 25.49 on October 15, 2026. The quote was timestamped 8:00 p.m. UTC.
The first price of the day is shown from the start of trading by the continuously updated real-time quote of Philips stock.
Next reporting date
Philips will publish its third-quarter 2026 results on November 3, 2026, at 7:00 a.m. CET, and will host a conference call at 10:00 a.m. CET, the company said on its investor-relations page.
Market context: Market report AEX.
